Promising lupus drug anifrolumab now tested in kids
NCT ID NCT05835310
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This phase 3 study tests anifrolumab, a biologic drug given by IV, in 100 children aged 5 to 18 with moderate to severe systemic lupus erythematosus (SLE). Participants continue their standard care and are randomly assigned to receive anifrolumab or a placebo. The goal is to see if the drug can reduce lupus activity and improve symptoms, while also checking safety and proper dosing in children.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Anifrolumab (a biologic drug given by IV infusion)
- What this could lead to
- If successful, this could provide a new treatment option to better control lupus in children, reducing disease flares and improving daily life.
- What could go wrong
- This is still an experimental treatment. It may not work better than placebo, and side effects like infections or allergic reactions are possible. The study is relatively small (100 participants).
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGPhoenix, Arizona, 85016, United States
-
Research Site
RECRUITINGLos Angeles, California, 90027, United States
-
Research Site
RECRUITINGWashington D.C., District of Columbia, 20010, United States
-
Research Site
RECRUITINGChicago, Illinois, 60611, United States
-
Research Site
RECRUITINGChicago, Illinois, 60637, United States
-
Research Site
NOT_YET_RECRUITINGNew Orleans, Louisiana, 70118, United States
-
Research Site
WITHDRAWNBethesda, Maryland, 20889, United States
-
Research Site
RECRUITINGSaint Paul, Minnesota, 55125, United States
-
Research Site
RECRUITINGNew Hyde Park, New York, 11042, United States
-
Research Site
RECRUITINGNew York, New York, 10032, United States
-
Research Site
RECRUITINGThe Bronx, New York, 10467, United States
-
Research Site
RECRUITINGValhalla, New York, 10595, United States
-
Research Site
RECRUITINGDurham, North Carolina, 27710, United States
-
Research Site
RECRUITINGCincinnati, Ohio, 45229, United States
-
Research Site
RECRUITINGCleveland, Ohio, 44109, United States
-
Research Site
RECRUITINGColumbus, Ohio, 43203, United States
-
Research Site
RECRUITINGPortland, Oregon, 97227, United States
-
Research Site
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Research Site
WITHDRAWNGreenville, South Carolina, 29605, United States
-
Research Site
RECRUITINGEl Paso, Texas, 79902, United States
-
Research Site
RECRUITINGHouston, Texas, 77030, United States
-
Research Site
RECRUITINGSalt Lake City, Utah, 84108, United States
-
Research Site
WITHDRAWNBuenos Aires, C1270, Argentina
-
Research Site
RECRUITINGCórdoba, 5000, Argentina
-
Research Site
RECRUITINGRosario, S2000PBJ, Argentina
-
Research Site
NOT_YET_RECRUITINGSan Miguel de Tucumán, T4000AXL, Argentina
-
Research Site
NOT_YET_RECRUITINGBelo Horizonte, 30130-100, Brazil
-
Research Site
RECRUITINGPorto Alegre, 90035-903, Brazil
-
Research Site
RECRUITINGRibeirão Preto, 14048-900, Brazil
-
Research Site
RECRUITINGSão Paulo, 04024-002, Brazil
-
Research Site
RECRUITINGSão Paulo, 05403 000, Brazil
-
Research Site
NOT_YET_RECRUITINGCalgary, British Columbia, T2N 4N1, Canada
-
Research Site
RECRUITINGVancouver, British Columbia, V6H 3N1, Canada
-
Research Site
RECRUITINGToronto, Ontario, M5G 1X8, Canada
-
Research Site
WITHDRAWNBeijing, 100020, China
-
Research Site
NOT_YET_RECRUITINGBeijing, 100032, China
-
Research Site
RECRUITINGBeijing, 100730, China
-
Research Site
RECRUITINGChangchun, 130021, China
-
Research Site
RECRUITINGChangsha, 410007, China
-
Research Site
NOT_YET_RECRUITINGNanjing, 210008, China
-
Research Site
RECRUITINGShanghai, 201102, China
-
Research Site
RECRUITINGSuzhou, 215002, China
-
Research Site
RECRUITINGWenzhou, 325027, China
-
Research Site
RECRUITINGZhengzhou, 450018, China
-
Research Site
RECRUITINGBarranquilla, 01800, Colombia
-
Research Site
WITHDRAWNMedellín, 050034, Colombia
-
Research Site
RECRUITINGBordeaux, 33076, France
-
Research Site
RECRUITINGBron, 69677, France
-
Research Site
RECRUITINGLe Kremlin-Bicêtre, 94275, France
-
Research Site
RECRUITINGLille, 59037, France
-
Research Site
RECRUITINGToulouse, 31300, France
-
Research Site
RECRUITINGBerlin, D-13353, Germany
-
Research Site
RECRUITINGFreiburg im Breisgau, 79106, Germany
-
Research Site
RECRUITINGSankt Augustin, 53757, Germany
-
Research Site
RECRUITINGGenova, 16148, Italy
-
Research Site
RECRUITINGMilan, 20122, Italy
-
Research Site
NOT_YET_RECRUITINGMilan, 20122, Italy
-
Research Site
RECRUITINGPadova, 35128, Italy
-
Research Site
RECRUITINGRoma, 00165, Italy
-
Research Site
RECRUITINGBunkyō City, 113-8519, Japan
-
Research Site
RECRUITINGBunkyō City, 113-8603, Japan
-
Research Site
RECRUITINGChiba, 266-0007, Japan
-
Research Site
RECRUITINGFuchu-shi, 183-8561, Japan
-
Research Site
RECRUITINGKawasaki-shi, 216-8511, Japan
-
Research Site
RECRUITINGKobe, 650-0047, Japan
-
Research Site
RECRUITINGObu-shi, 474-8710, Japan
-
Research Site
RECRUITINGShinjuku-ku, 162-8666, Japan
-
Research Site
RECRUITINGYokohama, 232 8555, Japan
-
Research Site
RECRUITINGYokohama, 236-0004, Japan
-
Research Site
NOT_YET_RECRUITINGAtizapán de Zaragoza, 52937, Mexico
-
Research Site
RECRUITINGGuadalajara, 44620, Mexico
-
Research Site
RECRUITINGMérida, 97070, Mexico
-
Research Site
RECRUITINGMéxico, 06720, Mexico
-
Research Site
RECRUITINGMonterrey, 64460, Mexico
-
Research Site
RECRUITINGLodź, 91-738, Poland
-
Research Site
RECRUITINGWarsaw, 02-637, Poland
-
Research Site
RECRUITINGWroclaw, 52-114, Poland
-
Research Site
WITHDRAWNLisbon, 1169-045, Portugal
-
Research Site
WITHDRAWNLisbon, 1649-035, Portugal
-
Research Site
WITHDRAWNPorto, 4200-319, Portugal
-
Research Site
WITHDRAWNCape Town, 7700, South Africa
-
Research Site
RECRUITINGEsplugues de Llobregat, 8950, Spain
-
Research Site
RECRUITINGMadrid, 28009, Spain
-
Research Site
RECRUITINGMadrid, 28034, Spain
-
Research Site
NOT_YET_RECRUITINGMadrid, 28046, Spain
-
Research Site
RECRUITINGMálaga, 29011, Spain
-
Research Site
NOT_YET_RECRUITINGSantiago de Compostela, 15706, Spain
-
Research Site
RECRUITINGValencia, 46026, Spain
-
Research Site
RECRUITINGAnkara, 06230, Turkey (Türkiye)
-
Research Site
RECRUITINGIstanbul, 34098, Turkey (Türkiye)
-
Research Site
RECRUITINGKayseri, 38039, Turkey (Türkiye)
-
Research Site
RECRUITINGUmraniye, 34760, Turkey (Türkiye)
-
Research Site
RECRUITINGBirmingham, B4 6NH, United Kingdom
-
Research Site
RECRUITINGBristol, BS2 8BJ, United Kingdom
-
Research Site
RECRUITINGLiverpool, L12 2AP, United Kingdom
-
Research Site
RECRUITINGLondon, NW1 2PG, United Kingdom
-
Research Site
RECRUITINGLondon, WC1N 3JH, United Kingdom
-
Research Site
RECRUITINGManchester, M13 9WL, United Kingdom
-
Research Site
RECRUITINGSouthampton, SO16 6YD, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smartphone app bridge the lupus care gap for women of color?
- Blood traps may reveal lupus kidney treatment success
- Can a peer coach help young people take control of their chronic illness?
- Lupus patients may get a boost from doctors checking their prescription refill records
- Engineered immune cells take aim at Hard-to-Treat autoimmune diseases
- New Four-Pronged antibody takes aim at lupus